Drug Trial Radar · NCT04139395
68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)
Last checked: Nov 20, 2026Latest source record: Aug 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jan 15, 2019
Primary completion
Dec 20, 2020
Study completion Dec 20, 2021
Sponsor
- Lead sponsor
- Carina Mari ApariciAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III study to evaluate 68Ga Citrate PET/MRI for detection of origin of fever of unknown origin.
Conditions
- Fever of Unknown Origin
Interventions
68Ga-Citrate PET/MRIDrug
Participants will be injected intravenously (IV) with 370 MBq of 68Ga Citrate. 45 -60 minutes after the radiopharmaceutical IV administration, whole body data acquisition at the PET/MRI suite will begin.
67Ga-Citrate SPECTDrug
67Ga-Citrate will be used as the radiotracer for a regular medical care SPECT scan
Positron Emission TomographyDevice
Imaging with 68Ga-Citrate PET/MRI
Magnetic Resonance ImagingDevice
Imaging with 68Ga-Citrate PET/MRI
SPECTDevice
Imaging with 67Ga-Citrate radiotracer. SPECT scan will be conducted as part of regular medical care.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Uptake detected by investigational imaging agentTime frame: Up to 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.